Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus

Human serum paraoxonase contributes to the anti-atherogenic effect of high-density lipoprotein cholesterol (HDL-C) and has been shown to protect both low-density lipoprotein cholesterol (LDL-C) and HDL-C against lipid peroxidation. We investigated the effects of rosiglitazone on paraoxonase activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Atamer, Y., Atamer, A., Can, A.S., Hekimoğlu, A., Ilhan, N., Yenice, N., Koçyiğit, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Cienífica 2013
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854442/
https://www.ncbi.nlm.nih.gov/pubmed/23802228
http://dx.doi.org/10.1590/1414-431X20132818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854442/
https://www.ncbi.nlm.nih.gov/pubmed/23802228
http://dx.doi.org/10.1590/1414-431X20132818

Ejemplares similares